Screener
aTyr Pharma ATYR Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $0— | $190K— | $0— | ||
| $6.75M-56.1% | $7.32M-38.1% | $10.89M-10.9% | $22.13M+49.5% | $15.38M+10.1% | ||
| $4.13M-16.1% | $4.12M+4.0% | $3.91M+8.7% | $4.81M+44.0% | $4.93M+47.5% | ||
| $10.88M-46.4% | $11.44M-27.5% | $14.8M-6.5% | $26.94M+48.5% | $20.31M+17.3% | ||
| -$10.88M+46.4% | -$11.44M+27.5% | -$14.8M+6.5% | -$26.75M-47.4% | -$20.31M-17.3% | ||
| $571K-26.9% | $644K-27.8% | $832K-2.3% | $999K+13.3% | $781K-22.6% | ||
| -$10.31M+47.2% | -$10.79M+27.5% | -$13.96M+6.7% | -$25.74M-49.2% | -$19.53M-19.8% | ||
| -$0.11+50.0% | -$0.11+35.3% | -$0.14+17.6% | -$0.26-13.0% | -$0.22+4.3% | ||
| -$10.71M+46.8% | -$11.27M+27.8% | -$14.63M+6.5% | -$26.58M-48.0% | -$20.15M-17.6% | ||
| -$10.88M+46.4% | -$11.44M+27.5% | -$14.8M+6.5% | -$26.75M-47.4% | -$20.31M-17.3% |
FAQ
- Is aTyr Pharma profitable?
- aTyr Pharma is not currently profitable: it reported a net loss of $60.8M over the trailing twelve months, a -39009.5% net margin.
- What is aTyr Pharma's earnings per share?
- aTyr Pharma's diluted EPS over the trailing twelve months is $-0.62.
- Where does aTyr Pharma's income statement data come from?
- Every line is extracted from aTyr Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.